In addition, the previous study examined the patients of clinical stages I and II (111/245) and patients of clinical stages III and IV (134/245), but our research mainly focused on patients of clinical stages I and II (300/377), and the differences in our results may indicate that CCNF expression is different in different stages of liver cancer, suggesting its potential prognostic utility. The gene discussed is CCNF; the disease is liver cancer.